Get 14 Days Free
(Alliance News) – Mycelx Technologies Corp on Tuesday said it has secured on a “promising” paid trial for the treatment of per-fluoroalkyl and poly-fluoroalkyl compounds in the US.
Mycelx is a Georgia, US-based clean water and clean air technology company.
The contract is for the provision of Mycelx’s fully containerised, mobile PFAS remediation system, which includes Mycelx infused cartridge filtration and Performer media.
Mycelx said the system will be used to treat PFAS-contaminated leachate from a solid waste landfill. The company expects the rental to demonstrate the ability of its technology to completely remove all identified PFAS chemicals to non-detectable concentrations in a single pass.
PFAS, or per-fluoroalkyl and poly-fluoroalkyl compounds, are a collection of long-lasting man-made toxic chemicals which present a global threat to human health and the environment.
Revenue from the trial is not expected to alter management’s revenue expectations for the year.
“The award is further proof of the strong momentum we are generating as a business in the PFAS solutions market, building on the Company’s success with its previous trial in America and installations in Australia with an important distributor. In addition, in scenarios of solid waste landfill, we continue to see a growing demand for technologies that are able to treat the co-contaminants that are present with PFAS,” said Chief Executive Officer Connie Mixon.
“As a group, we are firmly focused on achieving greater market share in three core areas; the Middle East, PFAS and REGEN. All of which we believe will be key growth drivers for Mycelx in 2023. We look forward to updating all our stakeholders on further corporate developments over the coming months,” Mixon added.
Mycelx shares were trading 0.5% higher at 35.18 pence each in London on Tuesday morning.
By Holly Beveridge; Alliance News reporter
Comments and questions to email@example.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.
Siemens Energy – Munich, Germany-based company with a product range including gas and steam …
Kropz PLC – African phosphate producer and developer – Makes third drawdown request under new …
(Alliance News) – Velocys PLC on Wednesday said it has agreed a sustainable aviation fuel proje…
Neometals Ltd – Australia-based company focused on advanced minerals projects and developing it…
Thursday 26 January AEW UK REIT PLCex-dividend payment dateArtemis Alpha Trust PLCdividend …
Mining companies are operating in a challenging environment but could now be the time to top up o…
THE WEEK: Morningstar columnist Rodney Hobson provides two pieces of advice to George Osborne, an…
Businesses that have competitive advantages within their industry are good candidates for dividen…
Morningstar reveals the top 10 best performers over the last five years
Morningstar OBSR reveals the top funds for investors seeking exposure to European equities
James Gard unpacks the FCA’s retirement income review, and argues it’s not just a test of the pen…
The move makes the Canadian artist the latest to cash in on the popularity of their back catalogu…
These six funds went from category winners to laggards over the course of one year
The reading misses the official target but is still above expectations
Apple Stock’s fair value estimate is now US$150, and its economic moat rating is ‘Wide.’
Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.
Connect With Us
The Morningstar Star Rating for Stocks is assigned based on an analyst’s estimate of a stocks fair value. It is projection/opinion and not a statement of fact. Morningstar assigns star ratings based on an analyst’s estimate of a stock’s fair value. Four components drive the Star Rating: (1) our assessment of the firm’s economic moat, (2) our estimate of the stock’s fair value, (3) our uncertainty around that fair value estimate and (4) the current market price. This process culminates in a single-point star rating that is updated daily. A 5-star represents a belief that the stock is a good value at its current price; a 1-star stock isn’t. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Morningstar Star Rating for Stocks, please visit here
Quantitative Fair Value Estimate represents Morningstar’s estimate of the per share dollar amount that a company’s equity is worth today. The Quantitative Fair Value Estimate is based on a statistical model derived from the Fair Value Estimate Morningstar’s equity analysts assign to companies which includes a financial forecast of the company. The Quantitative Fair Value Estimate is calculated daily. It is a projection/opinion and not a statement of fact. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Quantiative Fair Value Estimate, please visit here
Mycelx Technologies clinches paid trial for PFAS treatment in US – Morningstar
Get 14 Days Free